PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Mar 30, 2026 · 10-K · 89 days after period end · 0001140361-26-012030
| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 |
|---|---|---|---|---|
| Net Income | -$7.56M | -$7.95M | -$10.90M | -$19.14M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 30, 2026 · 89 d after period end
